Made this post on another site. I believe it, but
Post# of 72440
One possible reason that nobody has ventured yet is that IPIX, thru LW, is in deep negotiation talks with BPs for OM and IBD and BPs are scared to death that their multi-year plan to drive IPIX into bankruptcy is about to explode in their faces.
Major BPs have been aware of IPIX and its two active drugs, Kevetrin and Brilacidin, and their staggering potential for years.
BPs have massive amounts of money, they know how to play hardball, and they are not averse to doing whatever is necessary to secure such profitable IP at rock bottom pricing.
I believe we have a BP or two that have been part of the concerted effort against the IPIX share price (and thus its ability to raise funds at reasonable rates) to try and drive it into bankruptcy so they could buy the IP for pennies. I think the action is funded thru offshore accounts and managed in the USA. The sum wouldn't put a dent in their cash positions but it has been extremely costly for IPIX both in time and money in bringing these powerhouse drugs to market. The plan involves naked shorts, teams of paid posters on message boards, the phony lawsuit brought against the company, what I consider to be outrageous placebo cures in our clinical trials that were standard deviations outside normal expectations (not too hard to find the handful of clinical trial sites and pay a few people at each site to do what they want to make sure the trials don't come out as strong as one would expect.
Most on this board have been shaking their heads as to the disconnect between the science and the stock price and the action against the company on many forums.
Some may say too fantastical to believe, but that is why the BPs know they can get away with it. They don't worry about the SEC, FINRA, or any other regulatory agency as they are paid off as well. If they weren't, we would have T+0 trade accountability in the market instead of the T+2 which gives MMs the right to steal from retail with naked shorts.